Merit Medical Acquires of BioSphere Medical

Merit Medical Systems, Inc.

today announced the completion of its acquisition of BioSphere Medical, Inc., a leading developer and marketer of embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations. As a result of the acquisition, Merit will assume BioSphere's leading position in the embolic treatment of uterine fibroids. Merit intends to maintain BioSphere's manufacturing facility in France and a scaled-down office in Massachusetts.